Citius pharmaceuticals to be added to russell 2000® index

Cranford, n.j., june 7, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on anti-infective products in adjunct cancer care, unique prescription products and stem cell therapy, today announced that it is set to be added to the russell 2000® index at the conclusion of the russell us indexes annual reconstitution, effective at the opening of the u.s. equity markets on june 28, 2021.
CTXR Ratings Summary
CTXR Quant Ranking